DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY AND FLUOROURACIL CHEMOTHERAPY

被引：97
作者：
DIASIO, RB
LU, ZH
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 11期
关键词：
D O I：
10.1200/JCO.1994.12.11.2239
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2239 / 2242
页数：4
相关论文
共 35 条
[1]  
AU JLS, 1982, CANCER RES, V42, P2930
[2]   DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY LEADING TO THYMINE-URACILURIA - AN INBORN ERROR OF PYRIMIDINE METABOLISM [J].
BERGER, R ;
STOKERDEVRIES, SA ;
WADMAN, SK ;
DURAN, M ;
BEEMER, FA ;
DEBREE, PK ;
WEITSBINNERTS, JJ ;
PENDERS, TJ ;
VANDERWOUDE, JK .
CLINICA CHIMICA ACTA, 1984, 141 (2-3) :227-234
[3]  
CHABNER BA, 1989, CANCER PRINCIPLES PR, P349
[4]   INHIBITION OF FLUOROPYRIMIDINE CATABOLISM BY BENZYLOXYBENZYLURACIL - POSSIBLE RELEVANCE TO REGIONAL CHEMOTHERAPY [J].
DAHER, GC ;
NAGUIB, FNM ;
ELKOUNI, MH ;
ZHANG, RW ;
SOONG, SJ ;
DIASIO, RB .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (12) :1887-1893
[5]   FAMILIAL DEFICIENCY OF DIHYDROPYRIMIDINE DEHYDROGENASE - BIOCHEMICAL BASIS FOR FAMILIAL PYRIMIDINEMIA AND SEVERE 5-FLUOROURACIL-INDUCED TOXICITY [J].
DIASIO, RB ;
BEAVERS, TL ;
CARPENTER, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (01) :47-51
[6]   CLINICAL-PHARMACOLOGY OF 5-FLUOROURACIL [J].
DIASIO, RB ;
HARRIS, BE .
CLINICAL PHARMACOKINETICS, 1989, 16 (04) :215-237
[7]  
DIASIO RB, IN PRESS J BIOL CHEM
[8]  
DIASIO RB, 1994, 8TH INT S PUR PRIM B
[9]   POPULATION STUDY OF DIHYDROPYRIMIDINE DEHYDROGENASE IN CANCER-PATIENTS [J].
ETIENNE, MC ;
LAGRANGE, JL ;
DASSONVILLE, O ;
FLEMING, R ;
THYSS, A ;
RENEE, N ;
SCHNEIDER, M ;
DEMARD, F ;
MILANO, G .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2248-2253
[10]  
FLEMING RA, 1993, EUR J CANCER, V29A, P740
1234